ЕФАВІРЕНЗ/ЕМТРІЦИТАБІН/ТЕНОФОВІРУ ДЕЗОПРОКСИЛУ ФУМАРАТ 600 МГ/200 МГ/300 МГ

उत्पाद अवलोकन

About ЕФАВІРЕНЗ/ЕМТРІЦИТАБІН/ТЕНОФОВІРУ ДЕЗОПРОКСИЛУ ФУМАРАТ 600 МГ/200 МГ/300 МГ

ЕФАВІРЕНЗ/ЕМТРІЦИТАБІН/ТЕНОФОВІРУ ДЕЗОПРОКСИЛУ ФУМАРАТ 600 МГ/200 МГ/300 МГ is a prescription medication containing a combination of Emtricitabine, tenofovir disoproxil, and efavirenz. This medication is used to treat HIV-1 infection in adults and children over 2 years old, and is also used in combination with other medications to prevent HIV-1 infection in adults at high risk of infection.

Key Benefits & Uses

• Treatment of HIV-1 infection in adults and children over 2 years old
• Prevention of HIV-1 infection in adults at high risk of infection
• Combination therapy for HIV-1 infection treatment

Active Ingredient & Action

Emtricitabine, tenofovir disoproxil, and efavirenz work together to inhibit the replication of the HIV-1 virus. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that blocks the reverse transcription of viral RNA into DNA. Tenofovir disoproxil is also an NRTI that inhibits the replication of HIV-1 by blocking the reverse transcription of viral RNA into DNA. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that binds to the reverse transcriptase enzyme and blocks the replication of HIV-1.

Important Notes

Before taking ЕФАВІРЕНЗ/ЕМТРІЦИТАБІН/ТЕНОФОВІРУ ДЕЗОПРОКСИЛУ ФУМАРАТ 600 МГ/200 МГ/300 МГ, inform your doctor if you have any medical conditions, including liver or kidney disease, or if you are taking any other medications. This medication may cause side effects such as nausea, vomiting, diarrhea, and fatigue. It is essential to follow the recommended dosage and usage instructions provided by your doctor or pharmacist.